Rituximab-induced acute pulmonary fibrosis

被引：43

作者：

Leon, RJ

Gonsalvo, A

Salas, R

Hidalgo, NC

机构：

[1] Univ S Florida, Tampa, FL 33620 USA

[2] Hidalgo Med Ctr, Zephyrhills, FL USA

来源：

MAYO CLINIC PROCEEDINGS | 2004年 / 79卷 / 07期

关键词：

D O I：

10.4065/79.7.949

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：949 / +

页数：2

相关论文

共 2 条

[1] Rituximab therapy in hematologic malignancy patients with circulating blood tumor cells: Association with increased infusion-related side effects and rapid blood tumor clearance [J].

Byrd, JC ;

Waselenko, JK ;

Maneatis, TJ ;

Murphy, T ;

Ward, FT ;

Monahan, BP ;

Sipe, MA ;

Donegan, S ;

White, CA .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) :791-795

[2] Rituximab chimeric Anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma:: Half of patients respond to a four-dose treatment program [J].

McLaughlin, P ;

Grillo-López, AJ ;

Link, BK ;

Levy, R ;

Czuczman, MS ;

Williams, ME ;

Heyman, MR ;

Bence-Bruckler, I ;

White, CA ;

Cabanillas, F ;

Jain, V ;

Ho, AD ;

Lister, J ;

Wey, K ;

Shen, D ;

Dallaire, BK .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2825-2833